Hypertension Pathophysiology: Mechanisms of Primary & Secondary HTN

Primary (Essential) Hypertension (~90–95%)

Multifactorial: genetic predisposition + environmental triggers → sustained ↑ peripheral vascular resistance (PVR) and/or ↑ cardiac output (CO).

Key Pathways

  • Renin-Angiotensin-Aldosterone System (RAAS): ↑ Ang II → vasoconstriction, aldosterone → Na+/water retention, vascular remodeling.
  • Sympathetic overactivity: ↑ NE release, ↓ reuptake → ↑ HR, contractility, renin release, vascular tone.
  • Endothelial dysfunction: ↓ NO, ↑ endothelin-1 → impaired vasodilation, inflammation, thrombosis.
  • Vascular remodeling: Media hypertrophy, lumen narrowing → ↑ PVR (structural autoregulation).
  • Renal pressure-natriuresis shift: Kidney requires higher pressure to excrete Na+ (Guyton model).
  • Sodium sensitivity: ~50% of hypertensives; genetic (ENaC, NCC variants), age, race.
  • Obesity/insulin resistance: ↑ leptin, ↑ SNS, RAAS activation, renal compression.

Secondary Hypertension (~5–10%)

CauseMechanismClues
Renovascular (RAS)Renal ischemia → ↑ renin → Ang IIAbdominal bruit, flash pulmonary edema, resistant HTN
Primary aldosteronismAldosterone → Na+ retention, K+ lossHypokalemia (spontaneous or diuretic-induced), resistant HTN
Cushing's syndromeCortisol → mineralocorticoid receptor activationCentral obesity, striae, glucose intolerance
PheochromocytomaCatecholamine excess → α/β stimulationParoxysmal HTN, headaches, sweating, palpitations
Thyroid diseaseHyper: ↑ CO, ↓ SVR; Hypo: ↑ PVR, diastolic HTNOther thyrotoxic/hypothyroid signs
Coarctation of aortaMechanical obstruction → ↑ upper body BPFemoral pulse delay, rib notching on CXR
OSAIntermittent hypoxia → SNS, RAAS, endothelial dysfunctionSnoring, witnessed apneas, daytime sleepiness

Target Organ Damage (Consequences)

  • Heart: LVH → diastolic dysfunction → HFpEF; coronary disease.
  • Brain: Stroke (ischemic/hemorrhagic), white matter lesions, dementia.
  • Kidney: Nephrosclerosis → CKD → ESRD.
  • Eyes: Hypertensive retinopathy (AV nicking, hemorrhages, papilledema).
  • Vessels: Atherosclerosis acceleration, aortic dissection, aneurysm.

Treatment Implications

Target pathophysiology: RAAS inhibitors (ACEi/ARB), CCBs, thiazides, β-blockers (specific indications), MRA (resistant HTN). Lifestyle: Na+ restriction, weight loss, exercise, alcohol moderation.

Hypertension - Related Articles